Theralase Technologies Balance Sheet Health
Financial Health criteria checks 6/6
Theralase Technologies has a total shareholder equity of CA$1.9M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$3.3M and CA$1.4M respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
Interest coverage ratio | n/a |
Cash | CA$43.91k |
Equity | CA$1.91m |
Total liabilities | CA$1.37m |
Total assets | CA$3.28m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TTX's short term assets (CA$1.5M) exceed its short term liabilities (CA$1.1M).
Long Term Liabilities: TTX's short term assets (CA$1.5M) exceed its long term liabilities (CA$293.9K).
Debt to Equity History and Analysis
Debt Level: TTX is debt free.
Reducing Debt: TTX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TTX has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: TTX is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.